mAbxience, a global fully-fledged biotech company, with over a decade of experience in the development, manufacture and commercialization of biopharmaceuticals, is expanding patient access to biological treatments throughout Europe.
MADRID, March 31, 2021 /PRNewswire/ -- On 31 March 2021, the European Commission (EC) has approved...
As Australia officially accepts CELPIP (Canadian English Language Proficiency Index Program) for visa applications, international students face new opportunities alongside unprecedented preparation ch...
Daily Bulletin
Induct For Work, the Australian platform for frontline onboarding and compliance, has launched Compliance Hub, a fully integrated, real-time workflow designed specifically for the fast-paced, highly m...
Daily Bulletin
Reporting is a critical part of every penetration testing engagement. After vulnerabilities have been identified and verified, the findings must be documented clearly and systematically to inform deve...
Daily Bulletin
